We are live on ! Find out more
BOLD

Audentes Therapeutics, Inc
BOLD

Delisted

BOLD was delisted on the 14th of January, 2020.

Back to rankings

89 hedge funds and large institutions have $768M invested in Audentes Therapeutics, Inc in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 19 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 19

67% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 12

16% more capital invested

Capital invested by funds: $660M → $768M (+$107M)

10% more funds holding

Funds holding: 81 → 89 (+8)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
89
Holders Change
+8
Holders Change %
+9.88%
% of All Funds
2.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
35
Reduced
19
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$31.3M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$26.6M
3
State Street
State Street
Massachusetts
+$8.83M
4
FCM
Farallon Capital Management
California
+$8.78M
5
Citadel Advisors
Citadel Advisors
Florida
+$6.28M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$31.6M
2
VVM
Versant Venture Management
California
-$16.5M
3
RG
Redmile Group
California
-$9.88M
4
DM
Deerfield Management
New York
-$9.19M
5
AllianceBernstein
AllianceBernstein
Tennessee
-$4.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
Lord, Abbett & Co
26
Lord, Abbett & Co
New Jersey
$4.96M +$4.36M +158,853 New
Two Sigma Investments
27
Two Sigma Investments
New York
$4.02M +$2.6M +94,565 +277%
JP Morgan Chase
28
JP Morgan Chase
New York
$3.82M +$1.23M +44,944 +58%
SFM
29
Sphera Funds Management
Israel
$2.97M – – –
SIM
30
Spark Investment Management
New York
$2.95M +$387K +14,100 +18%
AC
31
Ascend Capital
California
$2.89M -$1.63M -59,210 -39%
Victory Capital Management
32
Victory Capital Management
Texas
$2.74M +$453K +16,500 +23%
NI
33
Numeric Investors
Massachusetts
$2.71M +$2.38M +86,600 New
Bank of New York Mellon
34
Bank of New York Mellon
New York
$2.58M +$760K +27,687 +51%
Goldman Sachs
35
Goldman Sachs
New York
$2.5M +$1.79M +65,092 +434%
EIM
36
Essex Investment Management
Massachusetts
$2.18M +$1.43M +52,184 +299%
Morgan Stanley
37
Morgan Stanley
New York
$2M -$2.37M -86,471 -57%
TCIM
38
TIAA CREF Investment Management
New York
$1.73M -$72.4K -2,636 -5%
Renaissance Technologies
39
Renaissance Technologies
New York
$1.67M +$1.47M +53,500 New
Deutsche Bank
40
Deutsche Bank
Germany
$1.58M +$966K +35,201 +228%
TD Asset Management
41
TD Asset Management
Ontario, Canada
$1.46M +$591K +21,510 +85%
Bank of America
42
Bank of America
North Carolina
$1.22M +$212K +7,712 +25%
Balyasny Asset Management
43
Balyasny Asset Management
Illinois
$1.13M +$995K +36,250 New
Charles Schwab
44
Charles Schwab
California
$1.08M +$247K +8,997 +35%
Wells Fargo
45
Wells Fargo
California
$1.06M +$538K +19,612 +136%
Swiss National Bank
46
Swiss National Bank
Switzerland
$1.04M +$912K +33,200 New
TA
47
Teachers Advisors
New York
$948K +$93.9K +3,421 +13%
Citigroup
48
Citigroup
New York
$852K +$721K +26,273 +2,651%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$809K +$32.6K +1,187 +5%
PPA
50
Parametric Portfolio Associates
Washington
$693K +$25.2K +919 +4%
1
2
3 4

BOLD Hedge Fund Activity: Q4 2017 in Review

89 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Audentes Therapeutics, Inc (BOLD) for Q4 2017, worth a combined $768M — up 16% from $660M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new BOLD positions and 12 closed out — a net gain of 8 holders — while 35 added to existing stakes and 19 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $31.3M. The largest seller was Adage Capital Partners, cutting an estimated $31.6M.

  • 89 institutional investors held Audentes Therapeutics, Inc (BOLD) as of Q4 2017, up from 81 in Q3 2017.
  • Funds reported $768M of Audentes Therapeutics, Inc stock for Q4 2017, up 16% quarter-over-quarter.
  • 20 funds opened new Audentes Therapeutics, Inc positions in Q4 2017 and 12 closed out, a net change of +8 holders.
  • The largest Audentes Therapeutics, Inc buyer in Q4 2017 was Fidelity Investments, an estimated $31.3M added.
  • The largest Audentes Therapeutics, Inc seller in Q4 2017 was Adage Capital Partners, an estimated $31.6M sold.

Based on aggregated 13F filings for Q4 2017.